NBGUX
Price
$31.85
Change
-$0.02 (-0.06%)
Updated
Sep 12 closing price
Net Assets
2.64B
RGAFX
Price
$87.81
Change
-$0.15 (-0.17%)
Updated
Sep 12 closing price
Net Assets
335.91B
Interact to see
Advertisement

NBGUX vs RGAFX

Header iconNBGUX vs RGAFX Comparison
Open Charts NBGUX vs RGAFXBanner chart's image
Neuberger Berman Large Cap Growth Adv
Price$31.85
Change-$0.02 (-0.06%)
VolumeN/A
Net Assets2.64B
American Funds Growth Fund of Amer R5
Price$87.81
Change-$0.15 (-0.17%)
VolumeN/A
Net Assets335.91B
NBGUX vs RGAFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NBGUX vs. RGAFX commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBGUX is a StrongBuy and RGAFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 336B vs. NBGUX (2.64B). RGAFX pays higher dividends than NBGUX: RGAFX (0.55) vs NBGUX (0.00). NBGUX was incepted earlier than RGAFX: NBGUX (29 years) vs RGAFX (23 years). NBGUX (1.44) is less costly to investors than RGAFX (0.34). NBGUX is a more actively managed with annual turnover of: 30.00 vs. RGAFX (25.00). NBGUX has a lower initial minimum investment than RGAFX: NBGUX (0) vs RGAFX (250). RGAFX annual gain was more profitable for investors over the last year : 18.27 vs. NBGUX (12.94). RGAFX return over 5 years is better than : 50.83 vs. NBGUX (44.17).
NBGUXRGAFXNBGUX / RGAFX
Total Expense Ratio1.440.34424%
Annual Report Gross Expense Ratio1.440.34424%
Fund Existence29 years23 years-
Gain YTD12.58417.99270%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.64B336B1%
Annual Yield % from dividends0.000.55-
Returns for 1 year12.9418.2771%
Returns for 3 years48.6261.2679%
Returns for 5 years44.1750.8387%
Returns for 10 years76.09104.9373%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX41.490.21
+0.51%
Patient Opportunity C
GGRCX16.830.05
+0.30%
Goldman Sachs Strategic Growth C
GTECX48.790.03
+0.06%
Gateway C
AWSIX17.87-0.06
-0.33%
Invesco Global Core Equity R5
BGGSX31.23-0.23
-0.73%
Baillie Gifford US Equity Growth I